Page 1113 - Clinical Immunology_ Principles and Practice ( PDFDrive )

ChaPTEr 79 Lymphomas 1077

23. Coiffier B, Thieblemont C, Van Den Neste E, et al. Long-term outcome of B-cell lymphomas resembling Burkitt lymphoma. Blood
patients in the LNH-98.5 trial, the first randomized study comparing 2014;123:1187–98.
rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a 35. Au WY, Weisenburger DD, Intragumtornchai T, et al. Clinical differences
study by the Groupe d’Etudes des Lymphomes de l’Adulte. Blood between nasal and extranasal natural killer/T-cell lymphoma: a study of
2010;116:2040–5. 136 cases from the International Peripheral T-Cell Lymphoma Project.
24. Dojcinov SD, Venkataraman G, Pittaluga S, et al. Age-related Blood 2009;1133931–7.
EBV-associated lymphoproliferative disorders in the Western population: 36. Quintanilla-Martinez L, Ridaura C, Nagl F, et al. Hydroa
a spectrum of reactive lymphoid hyperplasia and lymphoma. Blood vacciniforme-like lymphoma: a chronic EBV+ lymphoproliferative
2011;117:4726–35. disorder with risk to develop a systemic lymphoma. Blood
25. Nicolae A, Pittaluga S, Abdullah S, et al. EBV-positive large B-cell 2013;122:3101–10.
lymphomas in young patients: a nodal lymphoma with evidence for a 37. Thompson PA, Lade S, Webster H, et al. Effusion-associated anaplastic
tolerogenic immune environment. Blood 2015;126:863–72. large cell lymphoma of the breast: time for it to be defined as a distinct
26. Dojcinov SD, Venkataraman G, Raffeld M, et al. EBV positive clinico-pathological entity. Haematologica 2010;95:1977–9.
mucocutaneous ulcer—a study of 26 cases associated with various 38. Nicolae A, Xi L, Pittaluga S, et al. Frequent STAT5B mutations in
sources of immunosuppression. Am J Surg Pathol 2010;34:405–17. gammadelta hepatosplenic T-cell lymphomas. Leukemia 2014;28:2244–8.
27. Taddesse-Heath L, Meloni-Ehrig A, et al. Plasmablastic lymphoma with 39. Deleeuw RJ, Zettl A, Klinker E, et al. Whole-genome analysis and HLA
MYC translocation: evidence for a common pathway in the generation of genotyping of enteropathy-type T-cell lymphoma reveals 2 distinct
plasmablastic features. Mod Pathol 2010;23:991–9. lymphoma subtypes. Gastroenterology 2007;132:1902–11.
28. Rosenwald A, Wright G, Leroy K, et al. Molecular diagnosis of primary 40. Nakagawa M, Schmitz R, Xiao W, et al. Gain-of-function CCR4
mediastinal B cell lymphoma identifies a clinically favorable subgroup of mutations in adult T cell leukemia/lymphoma. J Exp Med
diffuse large B cell lymphoma related to Hodgkin lymphoma. J Exp Med 2014;211:2497–505.
2003;198:851–62. 41. Kataoka K, Nagata Y, Kitanaka A, et al. Integrated molecular analysis of
29. Traverse-Glehen A, Pittaluga S, Gaulard P, et al. Mediastinal gray zone adult T cell leukemia/lymphoma. Nat Genet 2015;47:1304–15.
lymphoma: the missing link between classic Hodgkin’s lymphoma and 42. Fan Z, Natkunam Y, Bair E, et al. Characterization of variant patterns of
mediastinal large B-cell lymphoma. Am J Surg Pathol 2005;29:1411–21. nodular lymphocyte predominant Hodgkin lymphoma with
30. Eberle FC, Rodriguez-Canales J, Wei L, et al. Methylation profiling of immunohistologic and clinical correlation. Am J Surg Pathol
mediastinal gray zone lymphoma reveals a distinctive signature with 2003;27:1346–56.
elements shared by classical Hodgkin’s lymphoma and primary 43. Hartmann S, Eichenauer DA, Plutschow A, et al. The prognostic impact
mediastinal large B-cell lymphoma. Haematologica 2011;96:558–66. of variant histology in nodular lymphocyte-predominant Hodgkin
31. Wilson WH, Grant C, et al. Therapy in primary mediastinal B-cell lymphoma: a report from the German Hodgkin Study Group (GHSG).
lymphoma. New Engl J Med 2013;369:283–4. Blood 2013;122:4246–52.
32. Dunleavy K, Pittaluga S, Maeda LS, et al. Dose-adjusted 44. Xing KH, Connors JM, Lai A, et al. Advanced-stage nodular lymphocyte
EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma. predominant Hodgkin lymphoma compared with classical Hodgkin
New Engl J Med 2013;368:1408–16. lymphoma: a matched pair outcome analysis. Blood 2014;123:3567–73.
33. Dave SS, Fu K, Wright GW, et al. Molecular diagnosis of Burkitt’s 45. Nam-Cha SH, Montes-Moreno S, Salcedo MT, et al. Lymphocyte-rich
lymphoma. N Engl J Med 2006;354:2431–42. classical Hodgkin’s lymphoma: distinctive tumor and microenvironment
34. Salaverria I, Martin-Guerrero I, Wagener R, et al. A recurrent 11q markers. Mod Pathol 2009;22:1006–15.
aberration pattern characterizes a subset of MYC-negative high-grade